An Open-Label, Randomized, Crossover Pharmacokinetic Study to Determine the Bioavailability, Safety and Tolerability of Single Doses of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat) in Patients With Refractory Epilepsy

Trial Profile

An Open-Label, Randomized, Crossover Pharmacokinetic Study to Determine the Bioavailability, Safety and Tolerability of Single Doses of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat) in Patients With Refractory Epilepsy

Discontinued
Phase of Trial: Phase II

Latest Information Update: 28 Jul 2017

At a glance

  • Drugs Diazepam (Primary) ; Diazepam
  • Indications Epilepsy
  • Focus Pharmacokinetics
  • Sponsors Acorda Therapeutics
  • Most Recent Events

    • 17 Feb 2017 Status changed from completed to discontinued.
    • 25 Jul 2016 Status changed from active, no longer recruiting to completed.
    • 10 Jun 2016 Planned End Date changed from 1 Nov 2016 to 1 Jul 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top